Shi Dan, Xie Duanyang, Zhang Hong, Zhao Hong, Huang Jian, Li Changming, Liu Yi, Lv Fei, The Erlinda, Liu Yuan, Yuan Tianyou, Wang Shiyi, Chen Jinjin, Pan Lei, Yu Zuoren, Liang Dandan, Zhu Weidong, Zhang Yuzhen, Li Li, Peng Luying, Li Jun, Chen Yi-Han
Key Laboratory of Basic Research in Cardiology of the Ministry of Education of China, Tongji University, Shanghai, China; Institute of Medical Genetics, Tongji University, Shanghai, China.
J Cell Mol Med. 2014 Oct;18(10):1992-9. doi: 10.1111/jcmm.12335. Epub 2014 Aug 5.
Ischaemic cardiac arrhythmias cause a large proportion of sudden cardiac deaths worldwide. The ischaemic arrhythmogenesis is primarily because of the dysfunction and adverse remodelling of sarcolemma ion channels. However, the potential regulators of sarcolemma ion channel turnover and function in ischaemic cardiac arrhythmias remains unknown. Our previous studies indicate that dynamin-2 (DNM2), a cardiac membrane-remodelling GTPase, modulates ion channels membrane trafficking in the cardiomyocytes. Here, we have found that DNM2 plays an important role in acute ischaemic arrhythmias. In rat ventricular tissues and primary cardiomyocytes subjected to acute ischaemic stress, the DNM2 protein and transcription levels were markedly down-regulated. This DNM2 reduction was coupled with severe ventricular arrhythmias. Moreover, we identified that the down-regulation of DNM2 within cardiomyocytes increases the action potential amplitude and prolongs the re-polarization duration by depressing the retrograde trafficking of Nav1.5 and Kir2.1 channels. These effects are likely to account for the DNM2 defect-induced arrhythmogenic potentials. These results suggest that DNM2, with its multi-ion channel targeting properties, could be a promising target for novel antiarrhythmic therapies.
缺血性心律失常在全球范围内导致了很大一部分心源性猝死。缺血性心律失常的发生主要是由于肌膜离子通道功能障碍和不良重塑。然而,在缺血性心律失常中,肌膜离子通道周转和功能的潜在调节因子仍不清楚。我们之前的研究表明,发动蛋白2(DNM2),一种参与心脏膜重塑的GTP酶,可调节心肌细胞中离子通道的膜转运。在此,我们发现DNM2在急性缺血性心律失常中起重要作用。在遭受急性缺血应激的大鼠心室组织和原代心肌细胞中,DNM2蛋白和转录水平显著下调。这种DNM2的减少与严重的室性心律失常相关。此外,我们发现心肌细胞内DNM2的下调通过抑制Nav1.5和Kir2.1通道的逆向转运增加动作电位幅度并延长复极持续时间。这些效应可能解释了DNM2缺陷诱导的致心律失常电位。这些结果表明,具有多离子通道靶向特性的DNM2可能是新型抗心律失常治疗的一个有前景的靶点。